Literature DB >> 21868764

Assembly and initial characterization of a panel of 85 genomically validated cell lines from diverse head and neck tumor sites.

Mei Zhao1, Daisuke Sano, Curtis R Pickering, Samar A Jasser, Ying C Henderson, Gary L Clayman, Erich M Sturgis, Thomas J Ow, Reuben Lotan, Thomas E Carey, Peter G Sacks, Jennifer R Grandis, David Sidransky, Nils Erik Heldin, Jeffrey N Myers.   

Abstract

PURPOSE: Human cell lines are useful for studying cancer biology and preclinically modeling cancer therapy, but can be misidentified and cross-contamination is unfortunately common. The purpose of this study was to develop a panel of validated head and neck cell lines representing the spectrum of tissue sites and histologies that could be used for studying the molecular, genetic, and phenotypic diversity of head and neck cancer.
METHODS: A panel of 122 clinically and phenotypically diverse head and neck cell lines from head and neck squamous cell carcinoma, thyroid cancer, cutaneous squamous cell carcinoma, adenoid cystic carcinoma, oral leukoplakia, immortalized primary keratinocytes, and normal epithelium was assembled from the collections of several individuals and institutions. Authenticity was verified by carrying out short tandem repeat analysis. Human papillomavirus (HPV) status and cell morphology were also determined.
RESULTS: Eighty-five of the 122 cell lines had unique genetic profiles. HPV-16 DNA was detected in 2 cell lines. These 85 cell lines included cell lines from the major head and neck primary tumor sites, and close examination shows a wide range of in vitro phenotypes.
CONCLUSIONS: This panel of 85 genomically validated head and neck cell lines represents a valuable resource for the head and neck cancer research community that can help advance understanding of the disease by providing a standard reference for cell lines that can be used for biological as well as preclinical studies. ©2011 AACR.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21868764      PMCID: PMC3229662          DOI: 10.1158/1078-0432.CCR-11-0690

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  31 in total

1.  Overexpression of NBS1 induces epithelial-mesenchymal transition and co-expression of NBS1 and Snail predicts metastasis of head and neck cancer.

Authors:  M-H Yang; S-Y Chang; S-H Chiou; C-J Liu; C-W Chi; P-M Chen; S-C Teng; K-J Wu
Journal:  Oncogene       Date:  2006-08-28       Impact factor: 9.867

Review 2.  Head and neck squamous cell carcinoma cell lines: established models and rationale for selection.

Authors:  Charles J Lin; Jennifer R Grandis; Thomas E Carey; Susanne M Gollin; Theresa L Whiteside; Wayne M Koch; Robert L Ferris; Stephen Y Lai
Journal:  Head Neck       Date:  2007-02       Impact factor: 3.147

Review 3.  Persistent use of "false" cell lines.

Authors:  Marc Lacroix
Journal:  Int J Cancer       Date:  2008-01-01       Impact factor: 7.396

4.  Salivary gland tumors in an Iranian population: a retrospective study of 130 cases.

Authors:  Mohammad Hussein Ansari
Journal:  J Oral Maxillofac Surg       Date:  2007-11       Impact factor: 1.895

5.  Case-control study of human papillomavirus and oropharyngeal cancer.

Authors:  Gypsyamber D'Souza; Aimee R Kreimer; Raphael Viscidi; Michael Pawlita; Carole Fakhry; Wayne M Koch; William H Westra; Maura L Gillison
Journal:  N Engl J Med       Date:  2007-05-10       Impact factor: 91.245

6.  TP53 mutations and survival in squamous-cell carcinoma of the head and neck.

Authors:  M Luana Poeta; Judith Manola; Meredith A Goldwasser; Arlene Forastiere; Nicole Benoit; Joseph A Califano; John A Ridge; Jarrard Goodwin; Daniel Kenady; John Saunders; William Westra; David Sidransky; Wayne M Koch
Journal:  N Engl J Med       Date:  2007-12-20       Impact factor: 91.245

Review 7.  Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers?

Authors:  Erich M Sturgis; Paul M Cinciripini
Journal:  Cancer       Date:  2007-10-01       Impact factor: 6.860

Review 8.  Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits.

Authors:  Kornelia Polyak; Robert A Weinberg
Journal:  Nat Rev Cancer       Date:  2009-03-05       Impact factor: 60.716

9.  DNA fingerprinting of the NCI-60 cell line panel.

Authors:  Philip L Lorenzi; William C Reinhold; Sudhir Varma; Amy A Hutchinson; Yves Pommier; Stephen J Chanock; John N Weinstein
Journal:  Mol Cancer Ther       Date:  2009-04       Impact factor: 6.261

10.  Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification.

Authors:  Rebecca E Schweppe; Joshua P Klopper; Christopher Korch; Umarani Pugazhenthi; Miriam Benezra; Jeffrey A Knauf; James A Fagin; Laura A Marlow; John A Copland; Robert C Smallridge; Bryan R Haugen
Journal:  J Clin Endocrinol Metab       Date:  2008-08-19       Impact factor: 5.958

View more
  143 in total

1.  Acute Tumor Lactate Perturbations as a Biomarker of Genotoxic Stress: Development of a Biochemical Model.

Authors:  Vlad C Sandulache; Yunyun Chen; Heath D Skinner; Tongtong Lu; Lei Feng; Laurence E Court; Jeffrey N Myers; Raymond E Meyn; Clifton D Fuller; James A Bankson; Stephen Y Lai
Journal:  Mol Cancer Ther       Date:  2015-09-16       Impact factor: 6.261

2.  HER3 Targeting Sensitizes HNSCC to Cetuximab by Reducing HER3 Activity and HER2/HER3 Dimerization: Evidence from Cell Line and Patient-Derived Xenograft Models.

Authors:  Dongsheng Wang; Guoqing Qian; Hongzheng Zhang; Kelly R Magliocca; Sreenivas Nannapaneni; A R M Ruhul Amin; Michael Rossi; Mihir Patel; Mark El-Deiry; J Trad Wadsworth; Zhengjia Chen; Fadlo R Khuri; Dong M Shin; Nabil F Saba; Zhuo G Chen
Journal:  Clin Cancer Res       Date:  2016-06-29       Impact factor: 12.531

3.  HRAS mutations and resistance to the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib in head and neck squamous cell carcinoma cells.

Authors:  J Hun Hah; Mei Zhao; Curtis R Pickering; Mitchell J Frederick; Genevieve A Andrews; Samar A Jasser; David R Fooshee; Zvonimir L Milas; Chad Galer; Daisuke Sano; William N William; Edward Kim; John Heymach; Lauren A Byers; Vali Papadimitrakopoulou; Jeffrey N Myers
Journal:  Head Neck       Date:  2014-03-20       Impact factor: 3.147

4.  A Novel Functional Splice Variant of AKT3 Defined by Analysis of Alternative Splice Expression in HPV-Positive Oropharyngeal Cancers.

Authors:  Theresa Guo; Akihiro Sakai; Bahman Afsari; Michael Considine; Ludmila Danilova; Alexander V Favorov; Srinivasan Yegnasubramanian; Dylan Z Kelley; Emily Flam; Patrick K Ha; Zubair Khan; Sarah J Wheelan; J Silvio Gutkind; Elana J Fertig; Daria A Gaykalova; Joseph Califano
Journal:  Cancer Res       Date:  2017-07-21       Impact factor: 12.701

5.  Acetyl-CoA carboxylase rewires cancer metabolism to allow cancer cells to survive inhibition of the Warburg effect by cetuximab.

Authors:  Jingtao Luo; Yun Hong; Yang Lu; Songbo Qiu; Bharat K R Chaganty; Lun Zhang; Xudong Wang; Qiang Li; Zhen Fan
Journal:  Cancer Lett       Date:  2016-09-28       Impact factor: 8.679

6.  Single agent nanoparticle for radiotherapy and radio-photothermal therapy in anaplastic thyroid cancer.

Authors:  Min Zhou; Yunyun Chen; Makoto Adachi; Xiaoxia Wen; Bill Erwin; Osama Mawlawi; Stephen Y Lai; Chun Li
Journal:  Biomaterials       Date:  2015-04-24       Impact factor: 12.479

7.  A proangiogenic signature is revealed in FGF-mediated bevacizumab-resistant head and neck squamous cell carcinoma.

Authors:  Rekha Gyanchandani; Marcus V Ortega Alves; Jeffrey N Myers; Seungwon Kim
Journal:  Mol Cancer Res       Date:  2013-10-03       Impact factor: 5.852

8.  Development and characterization of HPV-positive and HPV-negative head and neck squamous cell carcinoma tumorgrafts.

Authors:  Randall J Kimple; Paul M Harari; Alexandra D Torres; Robert Z Yang; Benjamin J Soriano; Menggang Yu; Eric A Armstrong; Grace C Blitzer; Molly A Smith; Laurel D Lorenz; Denis Lee; David T Yang; Timothy M McCulloch; Gregory K Hartig; Paul F Lambert
Journal:  Clin Cancer Res       Date:  2012-12-18       Impact factor: 12.531

Review 9.  Essentials of oral cancer.

Authors:  César Rivera
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

10.  Integrative genomic characterization of oral squamous cell carcinoma identifies frequent somatic drivers.

Authors:  Curtis R Pickering; Jiexin Zhang; Suk Young Yoo; Linnea Bengtsson; Shhyam Moorthy; David M Neskey; Mei Zhao; Marcus V Ortega Alves; Kyle Chang; Jennifer Drummond; Elsa Cortez; Tong-Xin Xie; Di Zhang; Woonbok Chung; Jean-Pierre J Issa; Patrick A Zweidler-McKay; Xifeng Wu; Adel K El-Naggar; John N Weinstein; Jing Wang; Donna M Muzny; Richard A Gibbs; David A Wheeler; Jeffrey N Myers; Mitchell J Frederick
Journal:  Cancer Discov       Date:  2013-04-25       Impact factor: 39.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.